Orange Book product · Brand (NDA)
JAVADIN
CLONIDINE HYDROCHLORIDE
At a glance
Oct 23, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 23, 2025
8 mo ago
Today
Patent 12233049 expires
Listed drug product patent expiration.
Jul 15, 2042
in 16 yr 4 mo
Patent 12440474 expires
Listed drug product patent expiration.
Jul 15, 2042
in 16 yr 4 mo
Pharmaceutical detail
Active ingredient
CLONIDINE HYDROCHLORIDE
Strength
0.02MG/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 220256
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2024ONYDA XRBrand (NDA)
NDA 217645 · TRIS PHARMA INC
- 2009JENLOGABrand (NDA)
NDA 022331 · CONCORDIA PHARMS INC
- 1996DURACLONBrand (NDA)
NDA 020615 · MYLAN INSTITUTIONAL
- —CATAPRESBrand (NDA)
NDA 017407 · BOEHRINGER INGELHEIM
- 2026CLONIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 070923 · TP ANDA HOLDINGS
- 2019CLONIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209675 · NOVAST LABS
- 2018CLONIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211433 · SOMERSET THERAPS LLC
- 2018CLONIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210680 · RUBICON RESEARCH
- 2018CLONIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210338 · JUBILANT GENERICS
- 2017CLONIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209686 · AJANTA PHARMA LTD
- 2017CLONIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210052 · AMNEAL PHARMS NY
- 2017CLONIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 209757 · XIAMEN LP PHARM CO
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12233049 | Jul 15, 2042 | in 16 yr 4 mo | Product |
| 12440474 | Jul 15, 2042 | in 16 yr 4 mo | Product |

